Details for Patent: RE32393

✉ Email this page to a colleague

Summary for Patent: RE32393

Patent landscape, scope, and claims:

Title:	Composition for enhancing the administration of pharmacologically active agents
Abstract:	According to the invention, the parenteral administration of water-insoluble pharmacologically active agents is enhanced wherein the agents are administered in the lipoid phase of a carrier emulsion comprising a microemulsion of a finely dispersed lipoid in an aqueous phase. The lipoid preferably has a mean particle size below 1 micron. This makes it possible to administer water-insoluble agents in high concentrations, and thus a lower dose, whereby a rapid onset of the pharmacological effect is accompanied by a markedly reduced incidence of injury to body tissues.
Inventor(s):	Wretlind; Karl A. J. (Stockholm, SE), Ljungberg; Stellan (Lidingo, SE), Hakansson; Ivan (Stockholm, SE), Ajaxon; Bengt M. (Upsala, SE)
Assignee:	KabiVitrum AB (Stockholm, SE)
Application Number:	06/605,760
Patent Claim Types: see list of patent claims	Composition; Compound; Dosage form; Use;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent RE32393

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: RE32393

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	12159/67	Sep 1, 1967

International Family Members for US Patent RE32393

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Germany	1792410	⤷ Subscribe
Denmark	129272	⤷ Subscribe
France	1593013	⤷ Subscribe
France	8152	⤷ Subscribe
United Kingdom	1229967	⤷ Subscribe
Netherlands	6812429	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.